Experts Look At The Meaning Of Myriad Case, One Year Later

Cal Irvine law school myriad conf Sept 2014

IRVINE, CALIFORNIA – Experts gathered here last week addressed the question of – one year later – what does the United States Supreme Court’s decision on human gene patents mean for scientific research and patent policy?

African Declaration On Internet Rights And Freedoms

africa-278x300

Infojustice.org writes: Last week, 23 civil society groups released the African Declaration on Internet Rights and Freedoms at the Internet Governance Forum, infojustice.org reports. The declaration is organized around twelve key principles, including Freedom of Expression and the Right to Information and Open Data.

Libraries May Be Permitted To Digitise Books Without Copyright Owner’s Consent, EU High Court Rules

Copyright 2

European Union governments may allow libraries to digitise books in their collection without rights owners’ consent in order to make them available at electronic reading posts, the European Court of Justice (ECJ) said on 11 September. If library users want to print works out on paper or store them on a USB stick, however, rights holders must be fairly compensated.

New European Commissioners Announced Under Changed Structure

organigramme_810_en

The structure of new European Commissioners and top officials was announced today, showing changes to the handling on intellectual property issues and many others.

Flexible IPR Approach For European Joint Innovation Projects

EU Flag

Applicants to the European “Innovation Communities” initiative have until 10 September to submit joint innovation proposals in the areas of healthy aging and raw materials. The aim is to create new organisations compliant with the European grant programme Horizon 2020, which will operate under flexible intellectual property rights’ policies in collaborative innovation projects.

WHO: Fight Ebola Now, Solve Patent Issues Later

WHO Ebola Briefing - Sept 2014

The world and the global health community have been taken by surprise by the worst outbreak of Ebola so far. The World Health Organization today (5 September) said a vaccine could be available in November 2014 if proven safe. So far, according to the WHO, intellectual property issues have not acted as a barrier to accessing potential treatments and vaccines, and the focus for now is on emergency measures to find health solutions.

Biosimilar Medicines Need Strong Regulation, IP Crucial For Innovation, Pharma Says

Biosimilar medicines might prove to be a new reservoir for innovation for the pharmaceutical industry. However, the complexity of their manufacture needs a stringent regulatory framework, according to the industry.

Market Failure, Not IP, The Issue In Ebola Treatment Shortage, WHO Says

Faced with the worst outbreak of Ebola since its discovery some 40 years ago, the world is scrambling for treatments. A World Health Organization-convened panel of experts has decided it is ethical to use experimental treatments. Why is there no treatment available even after 40 years? Market failure, not intellectual property rights, says the WHO.

World Drug Regulatory Authorities Meet In Brazil; Biosimilars In Focus

Drug regulatory authorities are meeting this week in Rio de Janeiro, Brazil to discuss global regulatory issues such as vaccine regulation, falsified products, and pharmacovigilance. A “pre-conference” focused on biosimilars, with civil society warning on barriers to access to those products.